chr20-45000494-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006282.5(STK4):​c.934G>A​(p.Val312Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.281 in 1,613,508 control chromosomes in the GnomAD database, including 68,167 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 5555 hom., cov: 32)
Exomes 𝑓: 0.28 ( 62612 hom. )

Consequence

STK4
NM_006282.5 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.77

Publications

31 publications found
Variant links:
Genes affected
STK4 (HGNC:11408): (serine/threonine kinase 4) The protein encoded by this gene is a cytoplasmic kinase that is structurally similar to the yeast Ste20p kinase, which acts upstream of the stress-induced mitogen-activated protein kinase cascade. The encoded protein can phosphorylate myelin basic protein and undergoes autophosphorylation. A caspase-cleaved fragment of the encoded protein has been shown to be capable of phosphorylating histone H2B. The particular phosphorylation catalyzed by this protein has been correlated with apoptosis, and it's possible that this protein induces the chromatin condensation observed in this process. [provided by RefSeq, Jul 2008]
STK4 Gene-Disease associations (from GenCC):
  • combined immunodeficiency due to STK4 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0019894838).
BP6
Variant 20-45000494-G-A is Benign according to our data. Variant chr20-45000494-G-A is described in ClinVar as Benign. ClinVar VariationId is 1169470.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.304 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STK4NM_006282.5 linkc.934G>A p.Val312Met missense_variant Exon 8 of 11 ENST00000372806.8 NP_006273.1 Q13043-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STK4ENST00000372806.8 linkc.934G>A p.Val312Met missense_variant Exon 8 of 11 1 NM_006282.5 ENSP00000361892.3 Q13043-1

Frequencies

GnomAD3 genomes
AF:
0.252
AC:
38239
AN:
152034
Hom.:
5551
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.147
Gnomad AMI
AF:
0.388
Gnomad AMR
AF:
0.214
Gnomad ASJ
AF:
0.414
Gnomad EAS
AF:
0.0154
Gnomad SAS
AF:
0.259
Gnomad FIN
AF:
0.394
Gnomad MID
AF:
0.427
Gnomad NFE
AF:
0.307
Gnomad OTH
AF:
0.286
GnomAD2 exomes
AF:
0.263
AC:
65988
AN:
250956
AF XY:
0.273
show subpopulations
Gnomad AFR exome
AF:
0.143
Gnomad AMR exome
AF:
0.146
Gnomad ASJ exome
AF:
0.413
Gnomad EAS exome
AF:
0.0115
Gnomad FIN exome
AF:
0.397
Gnomad NFE exome
AF:
0.311
Gnomad OTH exome
AF:
0.296
GnomAD4 exome
AF:
0.284
AC:
415719
AN:
1461356
Hom.:
62612
Cov.:
34
AF XY:
0.287
AC XY:
208479
AN XY:
726974
show subpopulations
African (AFR)
AF:
0.142
AC:
4738
AN:
33472
American (AMR)
AF:
0.154
AC:
6879
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.414
AC:
10800
AN:
26112
East Asian (EAS)
AF:
0.0122
AC:
483
AN:
39696
South Asian (SAS)
AF:
0.282
AC:
24348
AN:
86212
European-Finnish (FIN)
AF:
0.393
AC:
20985
AN:
53364
Middle Eastern (MID)
AF:
0.348
AC:
2008
AN:
5766
European-Non Finnish (NFE)
AF:
0.295
AC:
328418
AN:
1111668
Other (OTH)
AF:
0.283
AC:
17060
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
16288
32577
48865
65154
81442
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10478
20956
31434
41912
52390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.251
AC:
38258
AN:
152152
Hom.:
5555
Cov.:
32
AF XY:
0.255
AC XY:
18935
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.147
AC:
6110
AN:
41528
American (AMR)
AF:
0.214
AC:
3276
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.414
AC:
1435
AN:
3470
East Asian (EAS)
AF:
0.0154
AC:
80
AN:
5184
South Asian (SAS)
AF:
0.260
AC:
1255
AN:
4822
European-Finnish (FIN)
AF:
0.394
AC:
4147
AN:
10538
Middle Eastern (MID)
AF:
0.432
AC:
127
AN:
294
European-Non Finnish (NFE)
AF:
0.307
AC:
20877
AN:
67990
Other (OTH)
AF:
0.283
AC:
597
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1411
2822
4233
5644
7055
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
398
796
1194
1592
1990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.285
Hom.:
20006
Bravo
AF:
0.230
TwinsUK
AF:
0.295
AC:
1095
ALSPAC
AF:
0.297
AC:
1146
ESP6500AA
AF:
0.153
AC:
674
ESP6500EA
AF:
0.312
AC:
2684
ExAC
AF:
0.264
AC:
31999
Asia WGS
AF:
0.135
AC:
473
AN:
3478
EpiCase
AF:
0.316
EpiControl
AF:
0.312

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Combined immunodeficiency due to STK4 deficiency Benign:2
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 43% of patients studied by a panel of primary immunodeficiencies. Number of patients: 41. Only high quality variants are reported. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.064
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.10
T;.;.
Eigen
Benign
0.022
Eigen_PC
Benign
0.21
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.76
T;T;T
MetaRNN
Benign
0.0020
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.2
L;.;L
PhyloP100
2.8
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-0.12
N;N;N
REVEL
Benign
0.12
Sift
Benign
0.13
T;T;T
Sift4G
Benign
0.12
T;T;T
Polyphen
0.0010
B;B;B
Vest4
0.080
MPC
0.31
ClinPred
0.0069
T
GERP RS
4.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.082
gMVP
0.30
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17420378; hg19: chr20-43629135; COSMIC: COSV65670082; COSMIC: COSV65670082; API